Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00103961 · ClinicalTrials.gov registry record

An Observational Study of People Who Have Recently Been Infected With HIV

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
500
Enrollment target

NCT00103961 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00103961 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
500 participants
Enrollment target

Study Summary

This is a long-term follow-up study of people who are identified during acute or recent HIV infection and are being followed at clinical research sites associated with the Acute HIV Infection and Early Disease Research Program (AIEDRP). The purpose of this study is to collect data on the immunological and virologic responses that occur early in the course of HIV infection in treatment-naive and treatment-experienced HIV infected adults. Study hypothesis: This study will examine the immunological responses that occur early in the course of HIV infection in treated and untreated individuals. The long-term follow-up of these subjects will help identify host immunological and genetic factors along with therapeutic strategies associated with control of viremia and delayed disease progression. In addition, this cohort will provide the recruiting mechanism to support future trials of therapy to restore immune function. Furthermore, this cohort will provide a population suitable to monitoring changing patterns in the transmission of drug resistant viral strains while also evaluating ongoing behavioral risk factors associated with HIV transmission.

Interventions

  • BEHAVIORAL Questionnaire

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2004-01
Est. Completion 2014-12

What the Registry Record Tells You About NCT00103961

The ClinicalTrials.gov registry entry for NCT00103961 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.

NCT00103961 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00103961 about?

NCT00103961 is a clinical study titled "An Observational Study of People Who Have Recently Been Infected With HIV". This is a long-term follow-up study of people who are identified during acute or recent HIV infection and are being followed at clinical research sites associated with the Acute HIV Infection and Early Disease Research Program (AIEDRP). The purpose of this study is to collect data on the immunologic...

What is the current status of trial NCT00103961?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2004-01. Estimated completion is 2014-12.

What interventions are being tested in trial NCT00103961?

The interventions under investigation include: Questionnaire (BEHAVIORAL).

Who is sponsoring clinical trial NCT00103961?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.